According to Relmada Therapeutics's latest financial reports the company's current earnings (TTM) are -HK$0.68 B. In 2023 the company made an earning of -HK$0.78 B an increase over its 2022 earnings that were of -HK$1.23 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.